Mountain background

Princeton Capital Partners

Providing a unique approach to fostering value creation and strategic support for smaller, undervalued public healthcare companies.

Learn More

Welcome to Princeton Capital Partners

Princeton Capital Partners is an investment firm formed to provide a unique approach to fostering value creation and strategic support for smaller, undervalued public healthcare companies.

The partners and advisors of Princeton Capital Partners have five decades of expertise in enhancing operations to drive margin expansion, cash flow, and sales growth. We also have the discipline and hands-on experience to engage in turn-around situations.

Strategy

Team

Portfolio

Strategy background

Our Strategy

Founded in December 2008, Princeton Capital Partners is an investment firm formed to provide a unique approach to fostering value creation and strategic support for smaller, undervalued public healthcare companies. We typically only make one new investment per quarter and hold concentrated positions in a handful of companies.

Princeton Capital Partners tends to be the largest or one of the largest investors in the companies in which we invest. Since we were founded, Princeton Capital has made fifty-one investments, twenty-four of which have been acquired by third parties. We focus on companies that we perceive as offering asymmetric risk with limited downside through strong balance sheets, unique assets and scale coupled with significant upside through clearly defined and achievable operational improvements, structural changes, or other catalysts.

Our managing partners each have over twenty years of experience in healthcare with deep operational, financial, M&A, sales, and marketing expertise. We work with the existing senior management at our portfolio companies to help them improve operations, enhance company credibility and positioning, and create long-term shareholder value. We are able to provide help both internally and through our broad network of healthcare professionals. We benefit by being aligned with management, providing objective and fresh thoughts and strategy, and helping them as much as possible. Princeton Capital Partners is based on the principle of patient but constructive long-term investments and strong, mutually beneficial partnerships with our portfolio companies.

Team background

Our Team

Gregory L. Wilson - Managing Director

Gregory L. Wilson

Managing Director

Gregory Wilson has been focused on healthcare for over 25 years and started Princeton Capital Partners, LLC in December 2008. Prior to that he was a Managing Director of Denali Partners. Prior to that Greg was CFO of Eclipsys, a health information technology company. He helped the Company grow from a small startup to one with a market capitalization exceeding $1 billion and over $250 Million in revenue. Prior to that Greg was a VP and Healthcare Equity Analyst at Lehman Brothers covering healthcare services, providers, and information technology. Greg earned an AB with Honors from Princeton University and a JD from the Vanderbilt University School of Law.

Brian Shulman - Managing Director

Brian Shulman

Managing Director

Brian Shulman's career in healthcare has spanned three decades. As President of the South Region for Eclipsys, Shulman built the team that led the country with over 300% growth in 2 years. Shulman's hands-on sales leadership with Enterprise Systems (ESI) and Baxter Healthcare provides a valuable asset for our operating companies. Shulman has had broad exposure to the technology, infrastructure and materials management essential to successful clinical and financial operations. Mr. Shulman also created a highly profitable web-based SaaS company with over 95% recurring revenue that he owned exclusively and ultimately sold to K12, Inc. Mr. Shulman earned a bachelor of science in management while Captain of Auburn University's SEC championship football team in 1988.

T. Jack Risenhoover - Managing Director

T. Jack Risenhoover

Managing Director

T. Jack Risenhoover has been a senior healthcare technology executive since 1997 with responsibilities ranging from sales and marketing to operations and administration. Jack is the Founder and CEO of Wiles Bolt, a leader in AI enhanced patient outcomes and specialty pharma capture. Jack is also the Managing Director for Georgetown Advisors and was a principal at Georgetown Capital Partners. Jack helped introduce robotic chemotherapy compounding to hospital pharmacies in North America. Jack was an early member of the executive team for Eclipsys Corporation (ECLP), including as general counsel through the IPO and multiple acquisitions of public and private companies. He led the legal, human resources, and information systems teams before taking on operating responsibilities as the President of the Mid-America Region. Jack began his career in financial services at Merrill Lynch. Jack is a member of the California Bar Association, holds a juris doctorate from Vanderbilt University, a master of business administration from the Universty of Oklahoma and a bachelor of science in Management from Pepperdine University.

Portfolio background